Hyperlipidemia and the rheumatic diseases

Norman T. Ilowite

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Premature atherosclerosis is a recognized complication of systemic lupus erythematosus. Atherosclerosis begins in the pediatric age group, and interventions directed toward prevention should begin in childhood as well. A possible cause of premature atherosclerosis is dyslipoproteinemia from the underlying chronic inflammatory disease or from corticosteroid therapy. A relationship between dyslipoproteinemia and anticardiolipin antibodies has been demonstrated. Dietary therapy is helpful, but many patients continue to have significant dyslipoproteinemia after both dietary modification and fish oil supplementation. Lipid-lowering drugs may be indicated in this subgroup. Potential mechanisms of dyslipoproteinemia are discussed.

Original languageEnglish (US)
Pages (from-to)455-458
Number of pages4
JournalCurrent opinion in rheumatology
Issue number5
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Hyperlipidemia and the rheumatic diseases'. Together they form a unique fingerprint.

Cite this